TM

Taslimarif Majjid Kanchakar

Active Director Director DIN 10109690
DIN 10109690 First appointment Apr 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Taslimarif Majjid Kanchakar

Data last updated:

Taslimarif Majjid Kanchakar is a Director at Shrisai Biomedicals Private Limited (since 2023). The company operates in Healthcare.

DIN 10109690
Primary Designation Director
Industry Healthcare
First Appointment 10 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shrisai Biomedicals Private Limited U46596PN2023PTC219389
Director10 Apr 20232023Active

Board colleagues of Taslimarif Majjid Kanchakar

NameDINCompanyDesignation
Ajambi Majjid Kanchagar10109691Shrisai Biomedicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shrisai Biomedicals Private Limited
Premium access

Shareholding and investment profile for Taslimarif Majjid Kanchakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Taslimarif Majjid Kanchakar

Taslimarif Majjid Kanchakar currently holds 1 directorship: Shrisai Biomedicals Private Limited (Director, since 10 Apr 2023).

Taslimarif Majjid Kanchakar was first appointed on 10 Apr 2023 as Director at Shrisai Biomedicals Private Limited.

The current boards of Taslimarif Majjid Kanchakar's companies include Ajambi Majjid Kanchagar (Shrisai Biomedicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available